Biotechnology BioMarin Announces Durable Hemostatic Efficacy Maintained Over 6 years in Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A May 31, 2022
Health Denali Therapeutics and Biogen Announce Initiation of Phase 2b Study of LRRK2 Inhibitor in Parkinson’s Disease May 31, 2022
Biotechnology argenx Announces the UK MHRA has Granted Early Access to Efgartigimod for Generalized Myasthenia Gravis May 31, 2022
Biotechnology AXSM LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Axsome Therapeutics, Inc. May 30, 2022
Biotechnology The Gross Law Firm Announces Class Actions on Behalf of Shareholders of LICY, BKKT and AXSM May 30, 2022
Search
Biotechnology
